iRhythm Holdings, Inc. (IRTC) Stock
1 member of Congress disclosed 1 trade in IRTC since 2019: 0 purchases and 1 sale, most recently Donna Shalala (sale, Jun 24, 2019). 5 of the hedge funds AlphaScala tracks reported IRTC in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Millennium Management's at $167.30M. Company insiders reported 0 open-market buys and 1 sale on SEC Form 4 in the 90 days to Nov 10, 2026.
Which members of Congress traded iRhythm Holdings, Inc. (IRTC)?
Most recent: Donna Shalala (sale, Jun 24, 2019); records start Jun 24, 2019.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Donna Shalala D-FL · House | 2019-06-24 | sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 9, 2026.
See all IRTC political trades →Which hedge funds own IRTC?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Millennium Management Israel Englander | 1.41M | $167.30M | -13% |
| D.E. Shaw David Shaw | 630K | $74.90M | +14% |
| Point72 Steve Cohen | 273K | $32.49M | -54% |
| Citadel Ken Griffin | 96K | $11.41M | -16% |
| Renaissance Technologies Jim Simons (founder) | 39K | $4.58M | -28% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are iRhythm Holdings, Inc. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Sep 2, 26 | Wilson Daniel G. | Chief Financial Officer | SELL | 773 | $94K |
| Aug 10, 26 | Blackford Quentin S. | President and CEO | SELL | 26.9K | $3.3M |
| Aug 10, 26 | Murphy Patrick Michael | CBO and CLO | SELL | 7.1K | $884K |
| Aug 10, 26 | Patterson Chad | CHIEF COMM & PRODUCT OFFICER | SELL | 7.1K | $884K |
| Aug 10, 26 | Shrishrimal Sumi | EVP, Chief Risk Officer | SELL | 5.4K | $670K |
| Aug 10, 26 | Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | SELL | 7.1K | $884K |
| Aug 3, 26 | Patterson Chad | CHIEF COMM & PRODUCT OFFICER | SELL | 2.7K | $331K |
| Aug 3, 26 | Smith Mervin | EVP Strategic Business Ops | SELL | 617 | $75K |
| Aug 3, 26 | Rodda Julianne | EVP, CHIEF PEOPLE OFFICER | SELL | 2.1K | $258K |
SEC Form 4 filings as of Nov 10, 2026
See cluster-buy signals across all tickers →IRTC price chart
Powered by TradingViewWhat does iRhythm Holdings, Inc. do?
iRhythm Technologies Inc. is a leading digital healthcare company that develops and commercializes wearable biosensors and cloud-based analytics for detecting, predicting, and preventing cardiac diseases. Its flagship Zio platform features an FDA-cleared, CE-marked, wire-free patch-based biosensor that records up to 14 days of continuous electrocardiogram (ECG) data, paired with proprietary AI-driven software that analyzes millions of heartbeats to deliver actionable clinical insights for diagnosing arrhythmias more efficiently than traditional methods. The Zio system supports ambulatory cardiac monitoring, including long-term continuous monitoring (LTCM) and mobile cardiac telemetry, enabling faster detection of conditions like atrial fibrillation across diverse patient populations, including those with cardio-kidney-metabolic diseases. iRhythm Technologies Inc. serves clinicians through services that emphasize patient-centric design, such as home self-application, high analyzable ECG time, and real-world evidence from large-scale studies. Operating in the U.S. core market, innovative channels, and internationally, the company plays a key role in advancing ambulatory ECG monitoring and data-driven cardiac diagnostics.